Brucella abortus induces mast cell activation through TLR-2 and TLR-4.

[1]  C. González-Espinosa,et al.  Valproic acid restricts mast cell activation by Listeria monocytogenes , 2022, Scientific Reports.

[2]  Helen Y Wang,et al.  Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity , 2022, Frontiers in Immunology.

[3]  N. Seyffert,et al.  Tumor Necrosis Factor Alpha Contributes to Inflammatory Pathology in the Placenta during Brucella abortus Infection , 2022, Infection and immunity.

[4]  J. Granek,et al.  Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens , 2021, Frontiers in Immunology.

[5]  C. Maldonado-Bernal,et al.  Role of Toll-like receptors in natural killer cell function in acute lymphoblastic leukemia , 2021, Oncology Letters.

[6]  C. González-Espinosa,et al.  Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles , 2021, Frontiers in Immunology.

[7]  J. Godfroid,et al.  Efficacy of Brucella abortus S19 and RB51 vaccine strains: a systematic review and meta-analysis. , 2021, Transboundary and emerging diseases.

[8]  A. Chávez-Blanco,et al.  Severe COVID‐19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin , 2021, Journal of leukocyte biology.

[9]  J. Gorvel,et al.  Brucella: Reservoirs and Niches in Animals and Humans , 2021, Pathogens.

[10]  H. McSorley,et al.  IL-33 facilitates rapid expulsion of the parasitic nematode Strongyloides ratti from the intestine via ILC2- and IL-9-driven mast cell activation , 2020, PLoS pathogens.

[11]  S. Oliveira,et al.  Lack of Interleukin-6 Affects IFN-γ and TNF-α Production and Early In Vivo Control of Brucella abortus Infection , 2020, Pathogens.

[12]  C. González-Espinosa,et al.  Signal Transduction Pathways Activated by Innate Immunity in Mast Cells: Translating Sensing of Changes into Specific Responses , 2020, Cells.

[13]  E. Moreno,et al.  The Role of Neutrophils in Brucellosis , 2020, Microbiology and Molecular Biology Reviews.

[14]  A. Chávez-Blanco,et al.  The histone deacetylase inhibitor valproic acid attenuates phospholipase Cγ2 and IgE‐mediated mast cell activation , 2020, Journal of leukocyte biology.

[15]  Danielle M. Williams,et al.  Lipopolysaccharide O-antigens—bacterial glycans made to measure , 2020, The Journal of Biological Chemistry.

[16]  Hongbin Wang,et al.  Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection , 2020, PLoS pathogens.

[17]  M. Moreno-Lafont,et al.  Immune Response to Mucosal Brucella Infection , 2019, Front. Immunol..

[18]  S. Deng,et al.  Roles of Toll-Like Receptors in Nitroxidative Stress in Mammals , 2019, Cells.

[19]  Javier Santos,et al.  Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis , 2019, Cells.

[20]  Y. Im,et al.  Cytokines production and toll-like receptors expression in human leukemic monocyte cells, THP-1, stimulated with Brucella abortus cellular antigens. , 2018, Microbial pathogenesis.

[21]  L. Arriaga-Pizano,et al.  Giardia lamblia: identification of molecules that contribute to direct mast cell activation , 2018, Parasitology Research.

[22]  A. Bielawska-Drózd,et al.  Brucella – Virulence Factors, Pathogenesis and Treatment , 2018, Polish journal of microbiology.

[23]  A. Di Nardo,et al.  Interaction of primary mast cells with Borrelia burgdorferi (sensu stricto): role in transmission and dissemination in C57BL/6 mice , 2017, Parasites & Vectors.

[24]  M. Delpino,et al.  Brucella and Osteoarticular Cell Activation: Partners in Crime , 2017, Front. Microbiol..

[25]  S. Ullrich,et al.  Listeria monocytogenes induces mast cell extracellular traps. , 2017, Immunobiology.

[26]  S. Akira,et al.  Toll-Like Receptor Signaling and Its Inducible Proteins , 2016, Microbiology spectrum.

[27]  S. Nedospasov,et al.  Mast-Cell-Derived TNF Amplifies CD8(+) Dendritic Cell Functionality and CD8(+) T Cell Priming. , 2015, Cell reports.

[28]  I. Estrada-García,et al.  Recognition of Candida albicans by Dectin-1 induces mast cell activation. , 2015, Immunobiology.

[29]  S. Galli,et al.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity , 2015, Mucosal Immunology.

[30]  A. Chávez-Blanco,et al.  Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity , 2014, Current respiratory medicine reviews.

[31]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[32]  Jiabo Ding,et al.  [Pattern recognition and activation effect of mast cells in vitro infected by Brucella suis S2]. , 2013, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[33]  Fernanda S. Oliveira,et al.  Critical Role of ASC Inflammasomes and Bacterial Type IV Secretion System in Caspase-1 Activation and Host Innate Resistance to Brucella abortus Infection , 2013, The Journal of Immunology.

[34]  E. Schelling,et al.  Global Burden of Human Brucellosis: A Systematic Review of Disease Frequency , 2012, PLoS neglected tropical diseases.

[35]  S. Bulfone-Paus,et al.  TLR signaling in mast cells: common and unique features , 2012, Front. Immun..

[36]  Kurt L Zimmerman,et al.  Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo. , 2012, Vaccine.

[37]  B. Haribabu,et al.  Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. , 2010, Immunity.

[38]  S. Abraham,et al.  Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.

[39]  P. Wolters,et al.  Mast Cell IL-6 Improves Survival from Klebsiella Pneumonia and Sepsis by Enhancing Neutrophil Killing1 , 2008, The Journal of Immunology.

[40]  D. Wakefield,et al.  A critical role for CCL2 and CCL3 chemokines in the regulation of polymorphonuclear neutrophils recruitment during corneal infection in mice , 2007, Immunology and cell biology.

[41]  J. Cazareth,et al.  Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes , 2007, The Journal of experimental medicine.

[42]  J. Kyriakis,et al.  Dissection of a Signaling Pathway by Which Pathogen-associated Molecular Patterns Recruit the JNK and p38 MAPKs and Trigger Cytokine Release* , 2007, Journal of Biological Chemistry.

[43]  C. Guzmán-Verri,et al.  Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of Infection , 2007, PloS one.

[44]  M. Tsai,et al.  Mast Cell-Associated TNF Promotes Dendritic Cell Migration1 , 2006, The Journal of Immunology.

[45]  S. Akira,et al.  MyD88, but Not Toll-Like Receptors 4 and 2, Is Required for Efficient Clearance of Brucella abortus , 2005, Infection and Immunity.

[46]  D. Gemsa,et al.  Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes , 2003, Journal of leukocyte biology.

[47]  M. Maurer,et al.  Pattern analysis of human cutaneous mast cell populations by total body surface mapping , 2003, The British journal of dermatology.

[48]  A. Cloeckaert,et al.  Molecular and immunological characterization of the major outer membrane proteins of Brucella. , 1996, FEMS microbiology letters.

[49]  P. Kubes,et al.  Leukocyte-endothelial cell interactions evoked by mast cells. , 1996, Cardiovascular research.

[50]  Zhanqi Liu,et al.  Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms , 1996, Infection and immunity.

[51]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[52]  G. Schurig,et al.  Biological properties of RB51; a stable rough strain of Brucella abortus. , 1991, Veterinary microbiology.

[53]  X. Xin.  Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine. , 1986, Vaccine.

[54]  W. Paton,et al.  Compound 48/80: a potent histamine liberator. , 1951, British journal of pharmacology and chemotherapy.